Register entry

Bausch Health US, LLC

Data as of · How to read this entry

Registered sites
1
Active NDC listings
92
Labeller names
3
Live patents
38
Exclusivities
1
Countries
1
Base
Canada
Authorisation

Registered operations

Analytical testing1Labelling1Finished drug manufacture1Packaging1
Sites

Registered establishments

1
EstablishmentAddressRegistered forFEI / DUNS
Bausch Health Companies Inc.Registrant: Bausch Health US, LLC100 Life Sciences Pkwy, Steinbach, Manitoba R5G 1Z7, Canada (CAN)Analytical testing, Labelling, Finished drug manufacture, Packaging3002806613253292734
Catalogue

Drug listings by form and route

92

92 active NDC listings: 88 human prescription drug, 3 human otc drug, 1 bulk ingredient. By marketing category: NDA 85, OTC MONOGRAPH DRUG 3, ANDA 2, BLA 1, BULK INGREDIENT 1.

Dosage formNDCs
cream13
gel13
tablet13
tablet, extended release12
capsule7
lotion7
capsule, extended release6
capsule, coated, extended release5
tablet, coated3
tablet, film coated3
solution2
capsule, liquid filled1
implant1
injection1
injection, powder, lyophilized, for solution1
RouteNDCs
oral52
topical35
intravenous1
ophthalmic1
subcutaneous1
Labeller name on the listingNDCs
bausch health us, llc50
bausch health us llc41
bausch health ireland limited1
Exclusivity

Patents and exclusivities

38
PatentProductCoversExpiry
7919483SOLODYNminocycline hydrochlorideuseMar 2027
7541347SOLODYNminocycline hydrochlorideuseApr 2027
7544373SOLODYNminocycline hydrochlorideproductApr 2027
10220049CABTREOadapalene; benzoyl peroxide; clindamycin phosphateproductJun 2029
10624918CABTREOadapalene; benzoyl peroxide; clindamycin phosphateuseJun 2029
9561208CABTREOadapalene; benzoyl peroxide; clindamycin phosphateproductJun 2029
8288434CABTREOadapalene; benzoyl peroxide; clindamycin phosphateproductAug 2029
10238645ZYCLARAimiquimoduseAug 2029
8598196ZYCLARAimiquimoduseAug 2029
10238644ZYCLARAimiquimoduseDec 2029
11318130ZYCLARAimiquimoduseDec 2029
8222270ZYCLARAimiquimoduseDec 2029
8236816ZYCLARAimiquimoduseDec 2029
8299109ZYCLARAimiquimoduseDec 2029
10918635ZYCLARAimiquimoduseApr 2030
11202752ZYCLARAimiquimoduseApr 2030
11850245ZYCLARAimiquimoduseApr 2030
9192615SOLODYNminocycline hydrochlorideproductNov 2031
9012484LUZUluliconazolesubstance, productSept 2033
9199977LUZUluliconazolesubstance, productSept 2033
9453006LUZUluliconazolesubstanceSept 2033
8980931LUZUluliconazoleproductApr 2034
11679116ARAZLOtazaroteneproductJun 2036
11311482ARAZLOtazaroteneuseMay 2038
12128137ARAZLOtazaroteneproductMay 2038
12128059CABTREOadapalene; benzoyl peroxide; clindamycin phosphateproductJul 2040
12133859CABTREOadapalene; benzoyl peroxide; clindamycin phosphateproductJul 2040
12138278CABTREOadapalene; benzoyl peroxide; clindamycin phosphateproductJul 2040
12616710CABTREOadapalene; benzoyl peroxide; clindamycin phosphateproductJul 2040
11389467CABTREOadapalene; benzoyl peroxide; clindamycin phosphateproductDec 2040
ProductExclusivityUntil
CABTREOADAPALENE; BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATENP New productOct 2026
Catalogue

Marketed products

93

Showing 92 of 93.

BrandGeneric nameForm / routeNDC
ANCOBONFlucytosinecapsule, oral0187-3554NDA
ANCOBONFlucytosinecapsule, oral0187-3555NDA
AcanyaClindamycin Phosphate and Benzoyl Peroxidegel, topical13548-132NDA
Altrenotretinoinlotion, topical0187-0005NDA
Aplenzinbupropion hydrobromidetablet, extended release, oral0187-5810NDA
Aplenzinbupropion hydrobromidetablet, extended release, oral0187-5811NDA
Aplenzinbupropion hydrobromidetablet, extended release, oral0187-5812NDA
Arazlotazarotenelotion, topical0187-2098NDA
Ativanlorazepamtablet, oral0187-0063NDA
Ativanlorazepamtablet, oral0187-0064NDA
Ativanlorazepamtablet, oral0187-0065NDA
AtralinTretinoingel, topical13548-070NDA
Benzamycinerythromycin and benzoyl peroxidekit0187-5205NDA
Bryhalihalobetasol propionatelotion, topical0187-0002NDA
Cabtreoclindamycin phosphate/benzoyl peroxide/adapalenegel, topical0187-0006NDA
CaladrylFerric Oxide Red, Zinc Oxide, and Pramoxine Hydrochloridelotion, topical0187-5465OTC MONOGRAPH DRUG
Caladryl ClearPRAMOXINE HYDROCHLORIDE and ZINC ACETATElotion, topical0187-5466OTC MONOGRAPH DRUG
CardizemDiltiazem Hydrochloridetablet, coated, oral0187-0771NDA
CardizemDiltiazem Hydrochloridetablet, coated, oral0187-0772NDA
CardizemDiltiazem Hydrochloridetablet, coated, oral0187-0792NDA
Cardizem CDdiltiazem hydrochloridecapsule, coated, extended release, oral0187-0795NDA
Cardizem CDdiltiazem hydrochloridecapsule, coated, extended release, oral0187-0796NDA
Cardizem CDdiltiazem hydrochloridecapsule, coated, extended release, oral0187-0797NDA
Cardizem CDdiltiazem hydrochloridecapsule, coated, extended release, oral0187-0798NDA
Cardizem CDdiltiazem hydrochloridecapsule, coated, extended release, oral0187-0799NDA
Cardizem LADiltiazem Hydrochloridetablet, extended release, oral0187-2045NDA
Cardizem LADiltiazem Hydrochloridetablet, extended release, oral0187-2046NDA
Cardizem LADiltiazem Hydrochloridetablet, extended release, oral0187-2047NDA
Cardizem LADiltiazem Hydrochloridetablet, extended release, oral0187-2048NDA
Cardizem LADiltiazem Hydrochloridetablet, extended release, oral0187-2049NDA
Cardizem LADiltiazem Hydrochloridetablet, extended release, oral0187-2050NDA
CesametNabilonecapsule, oral0187-1231NDA
ClindagelCLINDAMYCINgel, topical16781-462NDA
Cupriminepenicillaminecapsule, oral25010-705NDA
Demsermetyrosinecapsule, oral25010-305NDA
Duobriihalobetasol propionate and tazarotenelotion, topical0187-0653NDA
EDECRINethacrynic acidtablet, oral25010-215NDA
EfudexFluorouracilcream, topical0187-3204NDA
JUBLIAefinaconazolesolution, topical0187-5400NDA
Klaronsulfacetamide sodiumlotion, topical0187-5198NDA
LibraxChlordiazepoxide Hydrochloride and Clidinium Bromidecapsule, oral0187-4100NDA
Lodosyncarbidopatablet, oral25010-711NDA
LuzuLULICONAZOLEcream, topical99207-850NDA
Mestinonpyridostigmine bromidetablet, oral0187-3010NDA
Mestinonpyridostigmine bromidesolution, oral0187-3012NDA
Mestinonpyridostigmine bromidetablet, extended release, oral0187-3013NDA
MysolinePrimidonetablet, oral66490-690NDA
MysolinePrimidonetablet, oral66490-691NDA
Noritatemetronidazolecream, topical0187-5202NDA
ONEXTONClindamycin Phosphate and Benzoyl Peroxidegel, topical0187-3050NDA
Pepcidfamotidinetablet, film coated, oral0187-4420ANDA
Pepcidfamotidinetablet, film coated, oral0187-4440ANDA
RenovaTretinoincream, topical0187-5150NDA
Retin-ATretinoincream, topical0187-5160NDA
Retin-ATretinoincream, topical0187-5162NDA
Retin-ATretinoincream, topical0187-5164NDA
Retin-ATretinoingel, topical0187-5170NDA
Retin-ATretinoingel, topical0187-5172NDA
Retin-A MICROTretinoingel, topical0187-5140NDA
Retin-A MICROTretinoingel, topical0187-5144NDA
Retin-A MICROTretinoingel, topical0187-5146NDA
Retin-A MICROTretinoingel, topical0187-5148NDA
SiliqBrodalumabinjection, subcutaneous0187-0004BLA
Syprinetrientine hydrochloridecapsule, oral0187-2120NDA
TIAZAC EXTENDED RELEASEdiltiazem hydrochloridecapsule, extended release, oral0187-2612NDA
TIAZAC EXTENDED RELEASEdiltiazem hydrochloridecapsule, extended release, oral0187-2613NDA
TIAZAC EXTENDED RELEASEdiltiazem hydrochloridecapsule, extended release, oral0187-2614NDA
TIAZAC EXTENDED RELEASEdiltiazem hydrochloridecapsule, extended release, oral0187-2615NDA
TIAZAC EXTENDED RELEASEdiltiazem hydrochloridecapsule, extended release, oral0187-2616NDA
TIAZAC EXTENDED RELEASEdiltiazem hydrochloridecapsule, extended release, oral0187-2617NDA
Targretinbexarotenegel, topical0187-5525NDA
Targretinbexarotenecapsule, liquid filled, oral0187-5526NDA
TasmarTolcaponetablet, film coated, oral0187-0938NDA
Tetracaine HydrochlorideTetracaine Hydrochloridesolution/ drops, ophthalmic0187-0920NDA
TheraSealDimethiconecream, topical0187-1660OTC MONOGRAPH DRUG
Vasereticenalapril maleate and hydrochlorothiazidetablet, oral0187-0146NDA
VasotecEnalapril Maleatetablet, oral0187-0140NDA
VasotecEnalapril Maleatetablet, oral0187-0141NDA
VasotecEnalapril Maleatetablet, oral0187-0142NDA
VasotecEnalapril Maleatetablet, oral0187-0143NDA
Visudyneverteporfin for injectioninjection, powder, lyophilized, for solution, intravenous0187-5600NDA
WELLBUTRIN XLbupropion hydrochloridetablet, extended release, oral0187-0730NDA
WELLBUTRIN XLbupropion hydrochloridetablet, extended release, oral0187-0731NDA
XereseAcyclovir and Hydrocortisonecream, topical0187-5104NDA
ZELAPARSELEGILINE HYDROCHLORIDEtablet, orally disintegrating, oral0187-0453NDA
ZIANAclindamycin phosphate and tretinoingel, topical99207-300NDA
Zoviraxacyclovirointment, topical0187-0993NDA
Zoviraxacyclovircream, topical0187-0994NDA
Zyclaraimiquimodcream, topical99207-270NDA
Zyclaraimiquimodcream, topical99207-271NDA
Zyclaraimiquimodcream, topical99207-276NDA
-fluocinolone acetonide implantimplant71071-001BULK INGREDIENT
Compare

Comparable companies in Canada

Enquiry

Common questions

Is Bausch Health US, LLC FDA approved?
Bausch Health US, LLC holds 1 FDA-registered establishment in Canada. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are Bausch Health US, LLC's drugs manufactured?
The FDA register lists Steinbach. Registered operations: analytical testing, labelling, finished drug manufacture, packaging.
What drugs does Bausch Health US, LLC make?
93 products are listed under Bausch Health US, LLC in the openFDA NDC Directory, most often as cream; gel; tablet. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.